Renaud Ronald C Jr - Net Worth and Insider Trading

Renaud Ronald C Jr Net Worth

The estimated net worth of Renaud Ronald C Jr is at least $4 Million dollars as of 2024-04-20. Renaud Ronald C Jr is the President & CEO of Cerevel Therapeutics Holdings Inc and owns about 83,857 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $4 Million. Renaud Ronald C Jr is also the CEO of Translate Bio Inc and owns about 0 shares of Translate Bio Inc (TBIO) stock worth over $0. Details can be seen in Renaud Ronald C Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Renaud Ronald C Jr has not made any transactions after 2023-08-03 and currently still holds the listed stock(s).

Transaction Summary of Renaud Ronald C Jr

To

Renaud Ronald C Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Renaud Ronald C Jr owns 8 companies in total, including Atara Biotherapeutics Inc (ATRA) , Translate Bio Inc (TBIO) , and Chimerix Inc (CMRX) among others .

Click here to see the complete history of Renaud Ronald C Jr’s form 4 insider trades.

Insider Ownership Summary of Renaud Ronald C Jr

Ticker Comapny Transaction Date Type of Owner
ATRA Atara Biotherapeutics Inc 2021-06-08 director
TBIO Translate Bio Inc 2021-09-14 director & Chief Executive Officer & other: President
CMRX Chimerix Inc 2014-12-17 director
AKBA Akebia Therapeutics Inc 2014-09-12 director
PTCT PTC Therapeutics Inc 2017-01-03 director
KERX Keryx Biopharmaceuticals Inc 2007-02-14 Chief Financial Officer
IKNA Ikena Oncology Inc 2021-03-25 director
CERE Cerevel Therapeutics Holdings Inc 2023-08-03 director & President & CEO

Renaud Ronald C Jr Latest Holdings Summary

Renaud Ronald C Jr currently owns a total of 2 stocks. Among these stocks, Renaud Ronald C Jr owns 83,857 shares of Cerevel Therapeutics Holdings Inc (CERE) as of August 3, 2023, with a value of $4 Million and a weighting of 100%. Renaud Ronald C Jr also owns 0 shares of Translate Bio Inc (TBIO) as of September 14, 2021, with a value of $0 and a weighting of 0%.

Latest Holdings of Renaud Ronald C Jr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CERE Cerevel Therapeutics Holdings Inc 2023-08-03 83,857 42.23 3,541,281
TBIO Translate Bio Inc 2021-09-14 0 37.36 0

Holding Weightings of Renaud Ronald C Jr


Renaud Ronald C Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Renaud Ronald C Jr has made a total of 1 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the acquisition of 83,857 shares on August 3, 2023, which cost Renaud Ronald C Jr around $2 Million.

According to the SEC Form 4 filings, Renaud Ronald C Jr has made a total of 1 transactions in Translate Bio Inc (TBIO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Translate Bio Inc is the sale of 954,053 shares on September 14, 2021, which brought Renaud Ronald C Jr around $36 Million.

Insider Trading History of Renaud Ronald C Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Renaud Ronald C Jr Trading Performance

GuruFocus tracks the stock performance after each of Renaud Ronald C Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Renaud Ronald C Jr is 10.94%. GuruFocus also compares Renaud Ronald C Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Renaud Ronald C Jr within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Renaud Ronald C Jr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Renaud Ronald C Jr

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.42 10.94 76.14
Relative Return to S&P 500(%) -0.73 14.13 65.99

Renaud Ronald C Jr Ownership Network

Ownership Network List of Renaud Ronald C Jr

No Data

Ownership Network Relation of Renaud Ronald C Jr


Renaud Ronald C Jr Owned Company Details

What does Atara Biotherapeutics Inc do?

Who are the key executives at Atara Biotherapeutics Inc?

Renaud Ronald C Jr is the director of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , SVP & GC & Secretary Amar Murugan , and director & President and CEO Pascal Touchon .

Atara Biotherapeutics Inc (ATRA) Insider Trades Summary

Over the past 18 months, Renaud Ronald C Jr made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 151,346 shares made by Pascal Touchon , a net sale of 43,245 shares made by Amar Murugan , and a net sale of 34,741 shares made by Eric J Hyllengren .

In summary, during the past 3 months, insiders sold 56,192 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 56,192 shares. During the past 18 months, 337,881 shares of Atara Biotherapeutics Inc (ATRA) were sold and 816,825 shares were bought by its insiders, resulting in a net purchase of 478,944 shares.

Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Atara Biotherapeutics Inc Insider Transactions

No Available Data

Renaud Ronald C Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Renaud Ronald C Jr. You might contact Renaud Ronald C Jr via mailing address: C/o Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge Ma 02109.

Discussions on Renaud Ronald C Jr

No discussions yet.